Cellectis SA (NASDAQ:CLLS)
| 2.00 BATS BZX Real-Time Price As of 12:44pm ET |  -0.04 / -1.96%Today’s Change | 1.77 Today|||52-Week Range 5.04 | -4.76% Year-to-Date |
Latest CLLS News | Press Releases
No recent news for Cellectis SA.
Today’s Trading
| Previous close | 2.04 |
| Today’s open | 2.02 |
| Day’s range | 2.00 - 2.03 |
| Volume | 3,150 |
| Average volume (3 months) | 129,576 |
| Market cap | $101.4M |
Data as of 12:44pm ET, 03/27/2023
Growth & Valuation
| Earnings growth (last year) | +8.54% |
| Earnings growth (this year) | +19.60% |
| Earnings growth (next 5 years) | +1.50% |
| Revenue growth (last year) | -66.54% |
| P/E ratio | NM |
| Price/Sales | 4.99 |
| Price/Book | 0.71 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GOSSGossamer Bio Inc | +0.07 | +6.28% |
| ---- | ||
| CTMXCytomX Therapeutics ... | +0.09 | +5.29% |
| MDWDMediwound Ltd | +0.51 | +4.32% |
Data as of 3:26pm ET, 03/27/2023
Financials
| Next reporting date | May 10, 2023 |
| EPS forecast (this quarter) | -$0.47 |
| Annual revenue (last year) | $19.2M |
| Annual profit (last year) | -$106.1M |
| Net profit margin | -473.60% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
